Focus on Childhood and Adolescent Mental Health: To Medicate or Not to Medicate?
J Clin Psychiatry 2007;68(7):1087-1087
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
In this issue of “Focus on Childhood and Adolescent Mental Health,” we present 4 articles describing when medication may and may not be the treatment of choice for youth with psychopathology and when other nonpharmacologic interventions may be helpful. The studies we present not only improve our understanding of the effectiveness, or lack thereof, of medications for novel indications or populations, but also provide additional tolerability and safety data regarding the use of these agents in pediatric populations. Yoo and colleagues examined aripiprazole for the treatment of tic disorders in an 8-week open-label study of 24 youth.